ARTICLE | Company News
MabVax Therapeutics Holdings, Juno Therapeutics, Memorial Sloan Kettering deal
October 20, 2014 7:00 AM UTC
MabVax, Memorial Sloan Kettering Cancer Center and Juno partnered to develop chimeric antigen receptor (CAR) T cell therapeutics for cancer. MabVax will supply antibody-targeting sequences derived fro...